OP0024 Use of novel patient-derived xenografts and molecular subtyping to improve precision medicine in high-grade serous ovarian cancer

2014 ◽  
Vol 50 ◽  
pp. e9
Author(s):  
V. Heong ◽  
M. Topp ◽  
R. Rutkowski ◽  
S. Ananda ◽  
S. Wong ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Precision Medicine ◽  
High Grade ◽  
Serous Ovarian Cancer ◽  
Molecular Subtyping

Development of ex vivo phenotypic assays to enable precision medicine in the context of high grade serous ovarian cancer

2016 ◽  
Vol 61 ◽  
pp. S85-S86
Author(s):  
L. Nelson ◽  
A. Tighe ◽  
A. Clamp ◽  
R. Edmondson ◽  
G. Jayson ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Precision Medicine ◽  
Ex Vivo ◽  
High Grade ◽  
Serous Ovarian Cancer

scholarly journals HIST1H2BB and MAGI2 Methylation and Somatic Mutations as Precision Medicine Biomarkers for Diagnosis and Prognosis of High-grade Serous Ovarian Cancer

2020 ◽  
Vol 13 (9) ◽  
pp. 783-794
Author(s):  
Blanca L. Valle ◽  
Sebastian Rodriguez-Torres ◽  
Elisabetta Kuhn ◽  
Teresa Díaz-Montes ◽  
Edgardo Parrilla-Castellar ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Precision Medicine ◽  
Somatic Mutations ◽  
High Grade ◽  
Serous Ovarian Cancer ◽  
Diagnosis And Prognosis

scholarly journals Sodium MRI with 3D-cones as a measure of tumour cellularity in high grade serous ovarian cancer

2019 ◽  
Vol 6 ◽  
pp. 156-162 ◽  
Author(s):  
Surrin S. Deen ◽  
Frank Riemer ◽  
Mary A. McLean ◽  
Andrew B. Gill ◽  
Joshua D. Kaggie ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
High Grade ◽  
Serous Ovarian Cancer ◽  
Sodium Mri ◽  
Tumour Cellularity
Sign in / Sign up

Export Citation Format

Share Document